Insulin Delivery Using the DBLG1 Closed-loop on Glycemic Control and PROMs in Adults Living With Type 1 Diabetes

NCT06154135 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 165

Last updated 2023-12-12

No results posted yet for this study

Summary

To evaluate the impact of the DBLG1 hybrid closed-loop system on glycemic control and patient-reported outcomes in adults living with type 1 diabetes under real-life conditions.

Conditions

  • Diabetes Mellitus, Type 1

Sponsors & Collaborators

  • Erasme University Hospital

    lead OTHER

Principal Investigators

  • Laurent Crenier, PhD · CUB - Hôpital Erasme

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-30
Primary Completion
2024-07-30
Completion
2026-07-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06154135 on ClinicalTrials.gov